Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
42.02
-0.72 (-1.68%)
At close: Sep 18, 2026, 4:00 PM EDT
41.00
-1.02 (-2.43%)
After-hours: Sep 18, 2026, 7:30 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $2.45 billion as of September 18, 2026. Its market cap has increased by 32.67% in one year.
Market Cap
2.45B
Enterprise Value
1.94B
1-Year Change
32.67%
Ranking
Category
Stock Price
$42.02
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.45B, an increase of 430.78%. That is a compound annual growth rate of 31.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.45B | 13.54% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.67B |
| Disc Medicine | 2.66B |
| Nurix Therapeutics | 2.65B |
| NewAmsterdam Pharma Company | 2.62B |
| Structure Therapeutics | 2.50B |
| Viridian Therapeutics | 2.48B |
| Mineralys Therapeutics | 2.47B |
| Vera Therapeutics | 2.47B |